171 related articles for article (PubMed ID: 2402935)
21. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
22. Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation.
Friedman KJ; LeBoit PE; Farmer ER
Arch Dermatol; 1988 May; 124(5):688-91. PubMed ID: 3284466
[TBL] [Abstract][Full Text] [Related]
23. Sclerodermatous chronic graft-versus-host disease presenting with dysphagia.
Tamagawa R; Takenaka H; Katoh N; Shimazaki C; Bamba H; Kishimoto S
Eur J Dermatol; 2006; 16(1):92-3. PubMed ID: 16436353
[No Abstract] [Full Text] [Related]
24. Rosai-Dorfman disease following bone marrow transplantation for pre-B cell acute lymphoblastic leukemia.
Ambati S; Chamyan G; Restrepo R; Escalon E; Fort J; Pefkarou A; Khatib ZA; Dehner LP
Pediatr Blood Cancer; 2008 Sep; 51(3):433-5. PubMed ID: 18493991
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
26. [Mucocutaneous and salivary manifestations of the graft vs host reaction after bone marrow transplantation].
d'Agay MF; Brocheriou C; Kuffer R; Gluckman E; Janin A; Saurat JH
Rev Stomatol Chir Maxillofac; 1984; 85(5):370-4. PubMed ID: 6393313
[TBL] [Abstract][Full Text] [Related]
27. [Changes in the oral mucosa in chronic secondary disease].
Akopian OG; Liubimova LS; Banchenko GV; Bykova IA; Savchenko VG
Stomatologiia (Mosk); 1996; 75(2):15-20. PubMed ID: 8754532
[TBL] [Abstract][Full Text] [Related]
28. Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide.
Nomura N; Uchida H; Nakamura H; Shirota T; Sakai N; Ito H; Suzuki A; Otaka M; Kimura Y; Toyama K
Transplant Proc; 1994 Aug; 26(4):2347. PubMed ID: 8066769
[No Abstract] [Full Text] [Related]
29. Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report.
Pelosini M; Galimberti S; Benedetti E; Caracciolo F; Fazzi R; Petrini M; Papineschi F
Leuk Res; 2007 Nov; 31(11):1603-4. PubMed ID: 17328949
[No Abstract] [Full Text] [Related]
30. Progressive autologous graft-versus-host disease induced by cyclosporin A.
Barredo JC; Yusuf U; Hahn A; Abboud MR; Laver J
Bone Marrow Transplant; 1996 Sep; 18(3):659-62. PubMed ID: 8879637
[TBL] [Abstract][Full Text] [Related]
31. Pathology of bone marrow transplantation.
Bombi JA; Palou J; Bruguera M; Feliu E; Martin-Ortega E; Rozman C; Cardesa A
Semin Diagn Pathol; 1992 Aug; 9(3):220-31. PubMed ID: 1523360
[TBL] [Abstract][Full Text] [Related]
32. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
[TBL] [Abstract][Full Text] [Related]
33. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
[TBL] [Abstract][Full Text] [Related]
34. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
35. Contrast media triggering cutaneous graft-versus-host disease.
Vavricka SR; Halter J; Furrer K; Wolfensberger U; Schanz U
Bone Marrow Transplant; 2002 Jun; 29(11):899-901. PubMed ID: 12080354
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
[TBL] [Abstract][Full Text] [Related]
37. An unrelated donor bone marrow transplant (BMT) for the treatment of Philadelphia chromosome-positive acute lymphocytic leukemia.
Aker SN; Vogelsan GB; Riley-Graves L; Manela EM; Stutzer CA; Beck J; Weisdorf S
Cancer Pract; 1993; 1(4):268-72. PubMed ID: 8111436
[No Abstract] [Full Text] [Related]
38. Bone marrow transplantation in childhood acute lymphoblastic leukemia with closely matched family donors in Hong Kong.
Yuen PM; Chik KW; Li CK; Shing MM; Lai H
Transplant Proc; 1996 Jun; 28(3):1748-9. PubMed ID: 8658866
[No Abstract] [Full Text] [Related]
39. Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Okano A; Shimazaki C; Ochiai N; Hatsuse M; Takahashi R; Ashihara E; Inaba T; Fujita N; Noda Y; Nakagawa M
Bone Marrow Transplant; 2001 Oct; 28(7):709-11. PubMed ID: 11704796
[TBL] [Abstract][Full Text] [Related]
40. The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
Teuffel O; Schrauder A; Sykora KW; Zimmermann M; Reiter A; Welte K; Schrappe M
Bone Marrow Transplant; 2005 Jul; 36(2):145-50. PubMed ID: 15908976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
